Case Study

Large PMA Study Of CRC Diagnostic

scientists data management clinical 450x300.jpg

This PMA study was being done to determine sensitivity and specificity using colonoscopy as the reference method, with lesions confirmed as malignant by histopathologic examination, quantitative molecular assays for KRAS mutations, aberrant NDRG4 and BMP3 methylation, and β-actin, plus a hemoglobin immunoassay. They were facing many challenges including ensuring that complex sample-management requirements were met; improving patient compliance with study obligations; monitoring data quality, including critical data on cancer staging; and ensuring adequate sample count and efficient sample collection with attention to distribution by age cohort. Continue reading to see what strategies for risk management and mitigation were among those that Health Decisions utilized in this study.

VIEW THE CASE STUDY!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: